Exelixis
EXEL
#1811
Rank
S$14.19 B
Marketcap
S$52.96
Share price
-1.36%
Change (1 day)
9.43%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company